Prof. Jianxing He’s team at Guangzhou Medical University First Affiliated Hospital has made a historic impact in robotic thoracic surgery. Their clinical research on the world’s first tubeless anatomical lung resection via intercostal single-port robotic approach—using the China-developed SHURUI® system—was published in Annals of Thoracic Surgery and honored with the ESTS Fellowship Award at the 2025 European Society of Thoracic Surgeons (ESTS) Congress.
The study demonstrated 100% success without conversion or additional ports, minimal blood loss, and high postoperative satisfaction, proving the system’s safety and feasibility in complex lung cancer procedures.
Beyond clinical performance, SHURUI® system introduces key engineering innovations: a nickel-titanium snake arm, 3D vision, and multi-channel trocar design—breaking through limitations of traditional robotic platforms.
At ESTS, the team presented a full 8-year research program spanning AI-assisted surgery, autonomous platforms, and surgical quality assessment, marking a major milestone in China's journey from technological imitation to global innovation leadership in intelligent, minimally invasive thoracic surgery.
The Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has been approved by the National Medical Products Administration (NMPA) in China for urology and gynecology laparoscopic surgeries. Surgeons who wish to learn the surgical operations of the SHURUI robot should contact Beijing Surgerii Robotics Co., Ltd. to participate in the official training program. Patients who want to participate in the registered clinical trials of the SHURUI robot should contact the official cooperative hospitals of Surgerii and consult with surgeons to determine their suitability for surgery with the SHURUI robot. Both surgeons and patients should carefully understand all information regarding the performance of surgeries by the SHURUI robot and its potential risks.
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other
trademarks and may not be used without permission.